-
ASSESSMENT OF CORONARY ARTERY DISEASE WITH COMPUTED TOMOGRAPHY ANGIOGRAPHY AND INFLAMMATORY AND IMMUNE ACTIVATION BIOMARKERS AMONG ADULTS WITH HIV ELIGIBLE FOR PRIMARY CARDIOVASCULAR PREVENTION
JAMA Network Open, June 2021.
Jun 29, 2021
-
PARTICIPANT PERSPECTIVES AND EXPERIENCES ENTERING AN INTENSIVELY MONITORED ANTIRETROVIRAL PAUSE
AIDS Research and Human Retroviruses, June 2021.
Jun 01, 2021
-
HIGHER COLORECTAL TISSUE HIV INFECTIVITY IN CISGENDER WOMEN COMPARED WITH MSM BEFORE AND DURING ORAL PREEXPOSURE PROPHYLAXIS
AIDS, April 2021.
Apr 06, 2021
-
RANDOMIZED TRIAL OF RUXOLITINIB IN ANTIRETROVIRAL-TREATED ADULTS WITH HIV
Clinical Infectious Diseases, March 2021.
Mar 06, 2021
-
POOR QUALITY OF LIFE AND INCOMPLETE SELF-REPORTED ADHERENCE PREDICT SECOND-LINE ART VIROLOGICAL FAILURE IN RESOURCE-LIMITED SETTINGS
AIDS Care, January 2021.
Jan 23, 2021
-
IDENTIFYING PEOPLE DURING THE ACUTE AND EARLY PHASES OF HIV
Clinical Infectious Diseases, December 2020.
Dec 31, 2020
-
A PHASE 1/2 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ROMIDESPIN IN PERSONS WITH HIV-1 ON SUPPRESSIVE ANTIRETROVIRAL THERAPY
The Journal of Infectious Diseases, December 2020.
Dec 21, 2020
-
HEPATITIS C VIRUS (HCV) DIRECT-ACTING ANTIVIRAL THERAPY IN PERSONS WITH HUMAN IMMUNODEFICIENCY VIRUS–HCV GENOTYPE 1 COINFECTION RESULTING IN HIGH RATE OF SUSTAINED VIROLOGIC RESPONSE AND VARIABLE IN NORMALIZATION OF SOLUBLE MARKERS OF IMMUNE ACTIVATION
The Journal of Infectious Diseases, October 2020.
Oct 15, 2020
-
PHYSICAL FUNCTION IMPAIRMENT AND FRAILTY IN MIDDLE-AGED PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS IN THE REPRIEVE TRIAL ANCILLARY STUDY PREPARE
The Journal of Infectious Diseases, July 2020.
Jul 09, 2020
-
ASSOCIATION OF MALE SEX AND OBESITY WITH RESIDUAL PLASMA HUMAN IMMUNODEFICIENCY VIRUS 1 VIREMIA IN PERSONS ON LONG-TERM ANTIRETROVIRAL THERAPY
The Journal of Infectious Diseases, June 2020.
Jun 30, 2020
-
BRIEF REPORT: SEX DIFFERENCES IN OUTCOMES FOR INDIVIDUALS PRESENTING FOR THIRD-LINE ANTIRETROVIRAL THERAPY
JAIDS, June 2020.
Jun 01, 2020
-
BRIEF REPORT: SEX DIFFERENCES IN OUTCOMES FOR INDIVIDUALS PRESENTING FOR THIRD-LINE ANTIRETROVIRAL THERAPY
JAIDS, June 2020.
Jun 01, 2020
